Table 1

Characteristics of ZZ-AATD and COPD patients employed in figures 3 and 4

Number of subjects56 (n=51 plasma donors, n=5 BAL/IS donors)15 (n=10 plasma donors, n=5 BAL/IS donors)
Age, years (mean±SD)50.29±14.470.86±6.71
Gender (male/female)31/258/7
FEV1 (% predicted)77.2±33.657.3±23.32
FVC (% predicted)105.7±23.987±5.29
FEV1/FVC (% predicted)58.7±20.6650±16.94
DLCO (% predicted)65.56±24.936±10.86
  • AATD, alpha-1 antitrypsin deficiency; BAL, bronchoalveolar lavage; BMI, body mass index; COPD, chronic obstructive pulmonary disease; DLCO, Diffusion capacity for carbon monoxide; FEV1, Forced expiratory volume in one second; FVC, Forced vital capacity; IS, induced sputum.